Format

Send to

Choose Destination

Canine osteosarcoma: amputation and chemoimmunotherapy.

Author information

1
Department of Medical Sciences, University of Wisconsin, Madison 53706, USA.

Abstract

Canine osteosarcoma is a highly metastatic cancer commonly seen in large breed dogs. At the time of diagnosis, approximately 90% to 95% of the dogs have established micrometastases. Dogs undergoing amputation alone have a median survival time of 3 to 4 months. Amputation followed by cisplatin chemotherapy increases median survival times to 9 to 11 months. When dogs are treated with amputation and cisplatin, followed by immunotherapy (with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine), median survival times increase to 14.4 months, the longest reported median survival time for dogs with osteosarcoma treated by amputation and any form of adjuvant therapy.

PMID:
8825571
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center